×
About 313 results

ALLMedicine™ Autoimmune Blistering Diseases Center

Research & Reviews  110 results

Lymphocyte-predominant lesional inflammatory infiltrates of the skin are associated wit...
https://doi.org/10.1111/cup.14395
Journal of Cutaneous Pathology; Cristian P, Sorina D et. al.

Jan 22nd, 2023 - Pemphigus is a potentially life-threatening autoimmune blistering disease. To date, studies assessing the association of histopathology with clinical phenotype are lacking. We sought to evaluate the main histopathologic findings and, also, the pot...

Eosinophilia and elevated IgE serum levels: a red flag: when your diagnosis is not a co...
https://doi.org/10.1007/s00011-023-01690-7
Inflammation Research : Official Journal of the European ... Criado PR, Miot HA et. al.

Jan 14th, 2023 - The hallmark of type 2 inflammation is eosinophilia and/or high IgE serum levels, mostly in atopic dermatitis. Nevertheless, many dermatoses may present similar findings. Our aim is to explore the biological and clinical spectrum of cutaneous mani...

Rituximab Treatment and Improvement of Health-Related Quality of Life in Patients With Pemphigus
https://www.mdedge.com/dermatology/article/260440/autoimmune-diseases/rituximab-treatment-and-improvement-health-related
Zeinab Aryanian, MD, Kamran Balighi, MD et. al.

Jan 3rd, 2023 - Pemphigus is a group of autoimmune blistering diseases characterized by the development of painful and flaccid blisters on the skin and/or mucous membranes. Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are 2 major subtypes and can be disti.

Follicular lymphoma manifests as multiple erosive and proliferative lesions of the oral...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675221
BMC Oral Health; Wu Y, Zhang Y et. al.

Nov 20th, 2022 - Erosion is one of the most common and basic lesions of oral mucosal diseases. Long-term refractory oral erosions, induced by autoimmune blistering diseases, infectious diseases, malignant diseases, and some rare conditions, may substantially reduc...

Rituximab in Subepidermal Blistering Diseases.
https://doi.org/10.1159/000526600
Dermatology (Basel, Switzerland); Tan WH, Sim J et. al.

Oct 28th, 2022 - Although rituximab is known to be effective in the treatment of pemphigus, its role in subepidermal autoimmune blistering diseases is unclear and currently limited to off-label use. This is a meta-analysis of case reports, case series, and retrosp...

see more →

Guidelines  3 results

European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, ini...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518905
Journal of the European Academy of Dermatology and Venere... Schmidt E, Rashid H et. al.

Jul 27th, 2021 - This guideline has been initiated by the task force Autoimmune Blistering Diseases of the European Academy of Dermatology and Venereology, including physicians from all relevant disciplines and patient organizations. It is a S3 consensus-based gui...

European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, ini...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457055
Journal of the European Academy of Dermatology and Venere... Rashid H, Lamberts A et. al.

Jul 11th, 2021 - This guideline on mucous membrane pemphigoid (MMP) has been elaborated by the Task Force for Autoimmune Blistering Diseases of the European Academy of Dermatology and Venereology (EADV) with a contribution of physicians from all relevant disciplin...

Japanese guidelines for the management of pemphigus.
https://doi.org/10.1111/1346-8138.12486
The Journal of Dermatology; , Amagai M et. al.

Jun 10th, 2014 - The Committee for Guidelines for the Management of Pemphigus was organized as one element of the Japanese Dermatological Association (JDA) and the Ministry of Health, Labour, and Welfare (MHLW) Research Project on Measures for Research Committee f...

see more →

Clinicaltrials.gov  2 results

Autoimmune Blistering Diseases Study
https://clinicaltrials.gov/ct2/show/NCT02753777

Feb 14th, 2022 - The disease severity instruments for pemphigus and BP, the Pemphigus Disease Area Index (PDAI) and the Bullous Pemphigoid Disease Area Index (BPDAI), respectively, have the potential to capture changes in all grades of disease activity, including ...

Rituximab in the Treatment of Patients With Bullous Pemphigoid
https://clinicaltrials.gov/ct2/show/NCT00286325

Apr 11th, 2013 - Bullous pemphigoid (BP) is an autoimmune blistering disease characterized clinically by the presence of severely itchy, tense blisters located over the trunk and extremities. BP is the most common of the autoimmune blistering diseases with an inci...

see more →

News  10 results

Rituximab Treatment and Improvement of Health-Related Quality of Life in Patients With Pemphigus
https://www.mdedge.com/dermatology/article/260440/autoimmune-diseases/rituximab-treatment-and-improvement-health-related
Zeinab Aryanian, MD, Kamran Balighi, MD et. al.

Jan 3rd, 2023 - Pemphigus is a group of autoimmune blistering diseases characterized by the development of painful and flaccid blisters on the skin and/or mucous membranes. Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are 2 major subtypes and can be disti.

Adolescence does not rule out bullous pemphigoid
https://www.mdedge.com/internalmedicine/article/194144/dermatology/adolescence-does-not-rule-out-bullous-pemphigoid?channel=39313
M. Alexander Otto

Feb 8th, 2019 - Include bullous pemphigoid in the differential diagnosis of autoimmune blistering diseases in adolescents. Dr.

Adolescence does not rule out bullous pemphigoid
https://www.mdedge.com/pediatrics/article/194144/dermatology/adolescence-does-not-rule-out-bullous-pemphigoid
M. Alexander Otto

Feb 8th, 2019 - Include bullous pemphigoid in the differential diagnosis of autoimmune blistering diseases in adolescents. Dr.

Immunologic testing is key to diagnosing autoimmune blistering diseases
https://www.mdedge.com/internalmedicine/article/147610/medical-dermatology/immunologic-testing-key-diagnosing-autoimmune
Jim Kling

Sep 21st, 2017 - SAN FRANCISCO – Blistering diseases are easily misdiagnosed and may resemble psoriasis or other conditions, but a routine histology and clinical examination aren’t sufficient diagnostic starting points. “You have to have some kind of immunological.

see more →